BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Buxhofer-Ausch V, Német O, Sheikh M, Andrikovics H, Reiner A, Ausch C, Mechtcheriakova D, Tordai A, Gleiss A, Özvegy-Laczka C, Jäger W, Thalhammer T. Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancer. Oncol Lett 2020;20:252. [PMID: 32994815 DOI: 10.3892/ol.2020.12115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Michalska K, Balcerczak E, Jeleń A, Saed L, Pietrzak J, Żebrowska-nawrocka M. Effects of the SLCO1B1 A388G single nucleotide polymorphism on the development, clinical parameters, treatment, and survival of multiple myeloma cases in a Polish population. Mol Biol Rep 2022. [DOI: 10.1007/s11033-022-08162-x] [Reference Citation Analysis]
2 Koller S, Kendler J, Karacs J, Wolf A, Kreuzinger C, Von Der Decken I, Mungenast F, Mechtcheriakova D, Schreiner W, Gleiss A, Jäger W, Cacsire Castillo-tong D, Thalhammer T. SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer. Front Pharmacol 2022;13:946348. [DOI: 10.3389/fphar.2022.946348] [Reference Citation Analysis]
3 Li Q, Zhang D, Wang H, Xie J, Peng L, Peng Y, Zheng X, Jiang J. SLCO4A1-AS1 Facilitates the Malignant Phenotype via miR-149-5p/STAT3 Axis in Gastric Cancer Cells. J Oncol 2021;2021:1698771. [PMID: 34712324 DOI: 10.1155/2021/1698771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]